Excited about Apabetalone, Go $RVXCF Apabetalon
Post# of 98002
Apabetalone has the potential to be a blockbuster drug!!!
-2 years into a phase III trial for patients with insulin dependent diabetes. 5 consecutive positive recommendations from the independent Data Safety Monitoring Board (DSMB) tracking the BETonMACE trial.
-Additional trials planned for orphan indication Fabry's Disease, and Chronic Kidney Disease for people on dialysis.
-Even Pfizer has taken notice of Apabetalone's potential in the treatment of a form of Muscular Dystrophy called Freidrich's Ataxia:
https://friedreichsataxianews.com/2017/05/25/...developed/
If it weren't for questions surrounding financing I think $RVXCF could have a valuation approaching $1 billion USD right now.....Expecting those financing issues to be addressed fully between now and the end of the year.
Go Resverlogix, Go!!!